Article
Detection of a new apolipoprotein-E mutation in type III hyperlipidemia using deoxyribonucleic acid restriction isotyping.
The Journal of clinical endocrinology and metabolism - 1 Mar 1994
Walden C C, Huff M W, Leiter L A, Connelly P W, Hegele R A
Abstract excerpt
While determining the apolipoprotein-E (apo-E) genotype of 22 patients with type III hyperlipidemia (HLP III) by restriction isotyping, we identified a new mutant form of apo-E by its unusual DNA restriction fragment length polymorphism pattern. DNA sequence analysis of a polymerase chain reaction-amplified portion of the proband's apo-E gene revealed the substitution of cysteine (TGC) for arginine (CGC) at...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
